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Background
Network Meta-Analysis (NMA)
• Combines evidence on multiple treatments from several studies
• Arranges treatments on a network structure joined by study 
evidence
• Provides a consistent set of treatment effect estimates
• Is routinely used to inform clinical guideline recommendations, 
technology appraisals
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Example: Headaches clinical guideline
Treatment
Mean change in 
headache days per 
month (95% CrI)
1 Placebo 0
2 Telmisartan -0.51 (-2.32, 1.27)
3 Amitriptyline -1.14 (-2.45, 0.16)
4 Divalproex Sodium 0.13 (-0.99, 1.23)
5 Gabapentin 0.00 (-1.60, 1.58)
6 Topiramate -1.04 (-1.52, -0.58)
7 Propranolol -1.19 (-2.20, -0.20)
8 Propranolol/Nadolol -0.60 (-1.65, 0.45)
(NICE CG151.1, 2015)
Minimal Clinically Important Difference 
(MCID) = 0.5 days per month
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Motivation






The quality of evidence reflects the extent to which 
our confidence in an estimate of the effect is adequate to support 
a particular recommendation.  (GRADE Handbook, 2013)
G-I-N Manchester 2018 5
Threshold Analysis
Create an invariant interval for a data point:
Invariant Interval
+ve threshold–ve threshold
How much would the evidence have to change before 
we reach a new recommendation?
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Threshold Analysis
We can do this at two “levels”:
• Study level
• Thresholds for each individual study estimate
• Contrast level
• Thresholds for combined body of evidence on a contrast
• Highly flexible due to approximation step
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Example: Headaches clinical guideline – contrast level
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Example: Headaches clinical guideline – contrast level
Example: Headaches clinical guideline – study level
Example: Headaches clinical guideline – study level
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Example: Social Anxiety
• 41 treatments, 100 studies
• Class effect model with 17 classes
• 84 direct comparisons and many “first 
order” loops 
⇒ GRADE impractical
Based on efficacy alone recommendation is 
CBT + Phenelzine (41)
(NCC-MH, 2013)





G-I-N Manchester 2018 14
Example: Social Anxiety
We can also use threshold analysis to investigate more specific 
concerns
• E.g. groups of treatments or studies with certain characteristics
Psychological treatment bias – could this affect the 
recommendation?
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Example: Social Anxiety – psychological treatment bias
G-I-N Manchester 2018 16
Conclusions
• Evidence quality and risk of bias are not sufficient to assess robustness of decisions
• Threshold analysis provides insight into the effects of changes in the evidence on 
treatment decisions
• We can have more confidence in recommendations where thresholds are large
• We can focus attention on the quality of decision-sensitive trials and contrasts
• More complex analyses can investigate specific concerns in the evidence
• Can be used with a range of decision rules or for decisions based on cost-effectiveness
Phillippo DM, Dias S, Ades AE, Didelez V and Welton NJ (2018). Sensitivity of treatment recommendations to 
bias in network meta‐analysis. J. R. Stat. Soc. A, 181: 843-867. doi:10.1111/rssa.12341
R package nmathresh package available on CRAN
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